Stanford professor Russ Altman emphasizes that AI is opening new opportunities to understand how medicines interact with specific proteins, and build more highly customized therapies. He points to DeepMind’s AlphaFold 2 deep learning system as a particularly powerful new tool for re-envisioning how drugs are discovered and designed.
Related
Dave Vasen,
brightwheel
Problem-Solving for a Unique Market [Entire Talk]
Listening to potential customers’ needs can be the key to unlocking a successful startup idea
Dave Vasen,
brightwheel
Problem-Solving for a Unique Market [Entire Talk]
Listening to potential customers’ needs can be the key to unlocking a successful startup idea
Maya Arengo,
Stanford University
Scaling a Climate Tech Company
An eCorner mini guide on the unique challenges that climate tech companies face when scaling, and how to overcome them.
Maya Arengo,
Stanford University
So You Want to Be a Climate Tech Entrepreneur
An eCorner mini guide on the current range of technologies within climate tech, and what kinds of funding for founders to secure.